TP53 status may predict benefit from cetuximab in high-risk, locally advanced rectal cancer: Results of the EXPERT-C trial

F. Sclafani; D. Gonzalez; D. Cunningham; S.H. Wilson; C. Peckitt; J. Tabernero; B. Glimelius; A. Cervantes; G. Brown; I. Chau

TP53 status may predict benefit from cetuximab in high-risk, locally advanced rectal cancer: Results of the EXPERT-C trial

F. Sclafani, D. Gonzalez, D. Cunningham, S.H. Wilson, C. Peckitt, J. Tabernero, B. Glimelius, A. Cervantes, G. Brown, I. Chau

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S4-S4
Journal	European Journal of Cancer
Volume	49
Publication status	Published - Sept 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209470600012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9

Cite this

Sclafani, F., Gonzalez, D., Cunningham, D., Wilson, S. H., Peckitt, C., Tabernero, J., Glimelius, B., Cervantes, A., Brown, G., & Chau, I. (2013). TP53 status may predict benefit from cetuximab in high-risk, locally advanced rectal cancer: Results of the EXPERT-C trial. European Journal of Cancer, 49, S4-S4. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209470600012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9

@article{4453a346e05c4c1d9eed2c37d5d68e83,

title = "TP53 status may predict benefit from cetuximab in high-risk, locally advanced rectal cancer: Results of the EXPERT-C trial",

author = "F. Sclafani and D. Gonzalez and D. Cunningham and S.H. Wilson and C. Peckitt and J. Tabernero and B. Glimelius and A. Cervantes and G. Brown and I. Chau",

year = "2013",

month = sep,

language = "English",

volume = "49",

pages = "S4--S4",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

}

Sclafani, F, Gonzalez, D, Cunningham, D, Wilson, SH, Peckitt, C, Tabernero, J, Glimelius, B, Cervantes, A, Brown, G & Chau, I 2013, 'TP53 status may predict benefit from cetuximab in high-risk, locally advanced rectal cancer: Results of the EXPERT-C trial', European Journal of Cancer, vol. 49, pp. S4-S4. <http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209470600012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9>

TY - JOUR

T1 - TP53 status may predict benefit from cetuximab in high-risk, locally advanced rectal cancer: Results of the EXPERT-C trial

AU - Sclafani, F.

AU - Gonzalez, D.

AU - Cunningham, D.

AU - Wilson, S.H.

AU - Peckitt, C.

AU - Tabernero, J.

AU - Glimelius, B.

AU - Cervantes, A.

AU - Brown, G.

AU - Chau, I.

PY - 2013/9

Y1 - 2013/9

M3 - Article

SN - 0959-8049

VL - 49

SP - S4-S4

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -